Need for an individualized and aggressive management of multinodular goiters of endemic zones by specially trained surgeons: Experience in western Nepal

World Journal of Surgery

Volumn 30, Issue 12, 2006, Pages 2101-2109

  Baxi, M ^a   Shetty, K J ^a   Baxi, J ^a   Basu, A ^a   Talwar, O P ^a   Smithi, S ^a   Tiwari, P K ^a   Maudar, K K ^a  

^a MANIPAL TEACHING HOSPITAL   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION BIOPSY; CANCER RISK; CHILD; COMPARATIVE STUDY; DECISION MAKING; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; ENDEMIC DISEASE; ENDEMIC GOITER; ENDOCRINE SURGERY; EUTHYROIDISM; FEMALE; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NEPAL; NODULAR GOITER; POSTOPERATIVE COMPLICATION; PROGNOSIS; RETROSPECTIVE STUDY; SOCIOECONOMICS; SURGICAL TECHNIQUE; SURGICAL TRAINING; THYROID CANCER; THYROID CARCINOMA; THYROID NODULE; THYROIDECTOMY; TOXIC GOITER; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GOITER, ENDEMIC; HUMANS; MALE; MIDDLE AGED; NEPAL; RETROSPECTIVE STUDIES; THYROID DISEASES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33845357375     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0346-9     Document Type: Article

References (71)

1. Benoist BD, Delange F. [Iodine deficiency: current situation and future prospects]. Sante 2002;12:9-17.
2. Macchia PE, Fenzi G. [Endemic goiter: clinical picture and evolution]. Ann Ist Super Sanita 1998;34:307-310.
3. Carditello A, Bartolotta, Starniolo G, et al. Solitary and multiple thyroid nodular pathology. Chir-Ital 1989;41:137-144.
4. Cordido F, Vidal JL, Valino D, et al. Different etiology of thyrotoxicosis as a function of previous prevalence of goiter. Med Clin (Barc) 1992;99:175-178.
5. Belfore A, La Rossa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age and multinodularity. Am J Med 1992;93:363-369.
6. Bacherstier C, Riccabona G, Totsch M, et al. Incidence and clinical characteristic of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 1997;7:733-741.
7. Corvilain B, Sande JV, Dumont JE, et al. Autonomy in endemic goiter. Thyroid 1998;8:107-113.
8. Reinwein D, Benker G, Konig MP, et al. Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study. Schweiz Med Wochenschr 1987;117:1245-1255.
9. Siegel RD, Lee SL. Toxic nodular goiter. Toxic adenoma and toxic multinodular goiter. Endocrinol Metab Clin North Am 1998;27:151-165.
10. Stanbury JB, Ermans AE, Bourdoux P, et al. Iodine induced hyerthyroidism: occurrence and epidemiology. Thyroid 1998;8:101-106.
11. Delange F, Benoist BD, Burgi H. ICCIDD Working Group. International Council for Control of Iodine Deficiency Disorders. Determining median urinary iodine concentration that indicates adequate iodine intake at population level. Bull WHO 2002;80:633-636.
12. Baral N, Ramprasad C, Lamsal M, et al. Assay of iodine deficiency status in three ecological regions of Nepal by a microdigestion method. Southeast Asian J Trop Med Pub Health 1999;30:527-531.
13. Murdoch DR, Harding EG, Dunn JT. Persistence of iodine deficiency 25 years after initial correction efforts in the Khumbu region of Nepal. N Z Med J 1999;112:266-268;
14. comment. N Z Med J 1999;112:389-390.
15. Baral N, Lamsal M, Koner BC, et al. Thyroid dysfunction in eastern Nepal. Southeast Asian J Trop Med Pub Health 2002;33:638-641.
16. Schulze KJ, West KP Jr, Gautschi LA, et al. Seasonality in urinary and household salt iodine content among pregnant and lactating women of the plains of Nepal. Eur J Clin Nutr 2003;57:969-976.
17. Baral N, Koner BC, Lamsal M, et al. Thyroid function testing in eastern Nepal and the impact of CME on subsequent requests. Trop Doct 2001;31:155-157.
18. Roman Sanziana A MD. Endocrine tumors: evaluation of the thyroid nodule. Curr Opin Oncol 2003;15:78-83.
19. Macchia PE, Fenzi G. [Endemic goiter: clinical picture and evolution]. Ann Ist Super Sanita 1998;34:307-310.
20. Pinchera A, Rago T, Vitti P. [Physiopathology of iodine deficiency]. Ann Ist Super Sanita 1998;34:301-305.
21. Dunn JT, Semigran MJ, Delange F. The prevention and management of iodine induced hyperthyroidism and its cardiac features. Thyroid 1998;8:101-106.
22. Erickson D, Gharib H, Li H, et al. Treatment of patients with toxic multinodular goiter. Thyroid 1998;8:277-282.
23. Rolla AR. Thyroid nodules in the elderly. Clin Geriatr Med 1995;11:259-269.
24. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid 1998;8:803-813.
25. Vetere F, Marlia E, Cucchi MC. Nodular hyperthyroidism: surgical experience and hypothesis of carcinogenic correlations. G Chir 1989;10:325-329.
26. Wiener JD. Long term follow-up in untreated Plummer's disease (autonomous goiter). Clin Nucl Med 1987;12:198-203.
27. Viase H, Lungu G, Viase L. Cardiac disturbances in thyrotoxicosis: diagnosis, incidence, clinical features and management. Endocrinologie 1991;29:155-160.
28. McMorrow ME. The elderly and thyrotoxicosis. AACN Clin Issues Crit Care Nurs 1992;3:114-119.
29. Knudsen N, Perrild H, Christiansen E, et al. Thyroid structure and size and two year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 2000;142:224-230.
30. Szpak S, Zeman M, Handkiewicz-Junak D, Kochanska-Dziurowicz A, et al. [Geographic differences in iodine supply in the Silesia terrain in relation to thyroid cancer risk]. Wiad Lek 2001;54:(Suppl 1) 169-175.
31. Rasmussen LB, Ovesen L, Bulow I, et al. Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, and serum thyroglobulin. Am J Clin Nutr 2002;76:1069-1076.
32. Hurley DL, Gharib H. Thyroid nodular disease: is it toxic or nontoxic, malignant or benign? Geriatrics 1995;50:24-26; discussion 29-31.
33. Huszno B, Szybinski Z, Trofimiuk M, et al. [Iodine deficiency and thyroid neoplasms in the Krakow region]. J Wiad Lek 2001;54:(Suppl 1) 163-168.
34. Passler C, Avanessian R, Kaczirek K, et al. Thyroid surgery in the geriatric patient. Arch Surg 2002;137:1243-1248.
35. Al Saleh MS, Al Kattan KM. Incidence of carcinoma in multinodular goiter in Saudi Arabia. J R Coll Surg Edinb 1994;39:106-108.
36. Schroder S, Marthaler B. Autonomy and malignancy of thyroid gland tumor, a critical analysis of the literature on the existence of hyperfunctioning follicular and papillary thyroid gland carcinomas. Pathologe 1999;17:349-357.
37. Thyroid Carcinoma Task Force. AACE/AAES Medical/Surgical Guidelines for Clinical Practice: management of thyroid carcinoma. Endocr Pract 2001;7:202-220.
38. Noguchi M, Katev N, Miyazaki I. Controversies in the surgical management of differentiated thyroid carcinoma. Int Surg 1996;81:163-167.
39. Eichhorn W, Tabler H, Lippold R, et al. Prognostic factors determining long term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty four patients undergoing therapy and aftercare at the same institution. Thyroid 2003;13:949-958.
40. Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma. A population based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-1991. Cancer 1997;79:564-573.
41. Ain KB. Anaplastic thyroid carcinoma: behavior, biology and therapeutic approaches. Thyroid 1999;8:715-726.
42. Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 1997;174:474-476.
43. Lin Jen Der, Huang BY. Comparison of the results of diagnosis and treatment between solid and cystic well-differentiated thyroid carcinomas. Thyroid 1998;8:661-666.
44. Nilsson O, Lindeberg J, Zedenius J, et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25 year period. World J Surg 1998;22:725-730.
45. Paik SS, Kim WS, Hong EK, et al. Poorly differentiated (insular) carcinoma of the thyroid gland - two cases report. J Korean Med Sci 1997;12:70-74.
46. Wasikowa R, Iwanicka Z, Zak T, et al. Nodular goiter and thyroid carcinoma in children and adolescents in a moderate endemic area (lower Silesia-Sudeten endemia) in the last twelve years. J Pediatr Endocrinol Metab 1999;12:645-652.
47. Ardito G, Mantovani M, Vincenzoni C, et al. Hyperthyroidism and carcinoma of the thyroid gland. Ann Ital Chir 1997;68:23-27; discussion 27-28.
48. Farkas EA, King TA, Bolton JS, et al. A comparison of total thyroidectomy and lobectomy in the treatment of dominant thyroid nodules. Am Surg 2002;68:678-682.
49. Mishra A, Agarwal A, Agarwal G, et al. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg 2001;25:307-310.
50. Pappalardo G, Guadalaxara A, Frattaroli FM, et al. Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg 1998;164:501-506.
51. Mattioli FP, Torre GC, Borgonovo G, et al. Surgical treatment of multinodular goiter. Ann Ital Chir 1996;67:341-345.
52. Duren M, Yavuz N, Bukey Y, et al. Impact of initial surgical treatment on survival of patients with differentiated thyroid cancer: experience of an endocrine surgery center in an iodine-deficient region. World J Surg 2000;24:1290-1294.
53. Delbridge L, Guinea AI, Reeve TS. Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 1999;134:1389-1393.
54. Prades JM, Dumollard JM, Timoshenko A, et al. Multinodular goiter: surgical management and histopathological findings. Eur Arch Otorhinolaryngol 2002;259:217-221.
55. Blum M, Hussain MA. Evidence and thoughts about thyroid nodules that grow after they have been identified as benign by aspiration cytology. Thyroid 2003;13:637-641;
56. comment. Thyroid 2004;14:86-87.
57. Feld S, et al. Thyroid Nodule Task Force. AACE Clinical Practice Guidelines for the Diagnosis and Management of Thyroid Nodules. Endocrine Pract 1996;2:78-84.
58. Uccheddu A, Cois A, Licheri S. The choice of intervention in surgical treatment of nontoxic diffuse multinodular goiter. Minerva Chir 1996;51:25-32.
59. Bennedbaek FN, Perrild H, Hegedus L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf) 1999;50:357-363.
60. Hamburger JI. Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations. Am J Med 1975;58:740-748.
61. Baldini M, Gallazzi M, Orsatti A, et al. Treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size. J Intern Med 2002;251:407-414.
62. Vulpoi C, Zbranca E, Mogos V, et al. [Thyroxine therapy in benign thyroid nodules]. Rev Med Chir Soc Med Nat Iasi 2001;105:95-100.
63. Benzarti S, Miled I, Bassoumi T, et al. [Thyroid surgery (356 cases): risks and complications]. Rev Laryngol Otol Rhinol (Bord) 2002;123:33-37.
64. Rosato L, Mondini G, Ginardi A, et al. [Incidence of complications of thyroid surgery]. Minerva Chir 2000;55:693-702.
65. Alter CA, Moshang T Jr. Diagnostic dilemma. The goiter. Pediatr Clin North Am 1991;38:567-578.
66. Hockauf H, Sailer R. Postoperative recurrent nerve palsy. Head Neck Surg 1982;4:380-384.
67. Svendsen FM, Badsgard SE, Nielsen PH, et al. Recurrent nerve injury after goiter surgery. Ugeskr Laeger 1990;152:1288-1290.
68. Runkel N, Riede E, Mann B, et al. Surgical training and vocal cord paralysis in benign thyroid disease. Arch Surg 1998;383:240-242.
69. Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998;228:320-330.
70. Harness JK, van Heerden JA, Lennquist S, et al. Future of thyroid surgery and training surgeons to meet the expectations of 2000 and beyond. World J Surg 2000;24:976-982.
71. Zedenius J, Wadstrom C, Delbridge L. Routine autotransplantation of at least one parathyroid gland during total thyroidectomy may reduce permanent hypoparathyroidism to zero. Aust N Z J Surg 1999;69:794-797.